US 11,980,639 B2
Methods for improving respiratory system health and increasing the concentration of hypothiocyanate ion in vertebrate lungs
James D. Lee, Kansas City, MO (US)
Assigned to SYNEXIS LLC, Lenexa, KS (US)
Filed by SYNEXIS LLC, Lenexa, KS (US)
Filed on Mar. 4, 2022, as Appl. No. 17/687,522.
Application 17/687,522 is a continuation of application No. 16/431,032, filed on Jun. 4, 2019, granted, now 11,426,428.
Application 16/431,032 is a continuation of application No. 14/913,286, abandoned, previously published as PCT/US2014/051914, filed on Aug. 20, 2014.
Claims priority of provisional application 61/867,971, filed on Aug. 20, 2013.
Prior Publication US 2022/0184118 A1, Jun. 16, 2022
This patent is subject to a terminal disclaimer.
Int. Cl. A61K 33/40 (2006.01); A61L 2/20 (2006.01); A61L 9/04 (2006.01)
CPC A61K 33/40 (2013.01) [A61L 2/208 (2013.01); A61L 9/04 (2013.01); A61L 2202/11 (2013.01); A61L 2209/211 (2013.01)] 12 Claims
OG exemplary drawing
 
1. A method for treating a respiratory illness in a subject in need thereof, said method comprising:
providing an enclosed space for treatment comprising a purified hydrogen peroxide gas (PHPG) that is substantially free of hydration and ozone, wherein said PHPG is present at a final concentration of up to 0.10 parts per million (ppm) in said enclosed space; and
treating said subject in need by exposing said subject to said enclosed space for at least one period of time to provide a therapeutic amount of PHPG, wherein said subject in need has a respiratory infection,
wherein said treating reduces the severity of the respiratory infection or reduces the duration of the respiratory infection,
wherein said subject in need is a human and is infected by an influenza virus, a severe acute respiratory syndrome (SARS) virus, a Middle East Respiratory Syndrome (MERS) virus, a respiratory syncytial virus (RSV), or the bacterium Streptococcus pneumoniae.